|Articles|February 3, 2009
'Injectible tan' leads to rapidly changing moles, experts say
Author(s)Allison Tsai
Dublin, Ireland - Melanotan, an unlicensed medicine that works by increasing the levels of melanin in a person's body after being injected, has been linked to rapidly changing moles, the Evening Herald reports.
Advertisement
Dublin, Ireland
- Melanotan, an unlicensed drug that works by increasing the levels of melanin in a person’s body after injection, has been linked to rapidly changing moles, the
Evening Herald
reports.
The United Kingdom’s Medicines and Healthcare products Regulatory Agency has warned consumers to avoid the product because it has not been tested for safety, quality or effectiveness and its side effects are unknown, according to the
Herald
.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Sanofi Discontinues Development of OX40L Inhibitor Amlitelimab in Atopic Dermatitis
2
SPD 2026: Clinical Considerations and Inclusive Communication in Pediatric Gender-Affirming Dermatology
3
Tailoring Pediatric Vitiligo Treatment: Insights from SPD 2026
4
Masterclass Insights: Optimizing Care for Ulcerated Hemangiomas and Café-au-Lait Macules
5







